Seeking Alpha

Isis Pharmaceuticals (ISIS) forms an alliance with Roche (RHHBY.OB) to utilize Isis' technology...

Isis Pharmaceuticals (ISIS) forms an alliance with Roche (RHHBY.OB) to utilize Isis' technology to develop innovative treatments for Huntington's disease. The companies will look to advance Isis' lead drug candidate which works by blocking the huntingtin protein. Isis will receive an upfront payment of $30M and may reap $362M in milestone payments and licensing fees going forward. 
Comments (1)
  • arthurs1
    , contributor
    Comments (345) | Send Message
     
    Excellent validation, Roche was one of the few big pharmas that was not partnered with ISIS. Another validation of the antisense platform.
    8 Apr 2013, 09:45 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|